A detailed history of F Dx Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, F Dx Advisors, Inc. holds 1,140 shares of AMGN stock, worth $301,518. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,140
Previous 1,336 14.67%
Holding current value
$301,518
Previous $417,000 11.99%
% of portfolio
0.1%
Previous 0.12%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$309.38 - $337.38 $60,638 - $66,126
-196 Reduced 14.67%
1,140 $367,000
Q2 2024

Aug 02, 2024

SELL
$262.75 - $319.31 $573,320 - $696,734
-2,182 Reduced 62.02%
1,336 $417,000
Q1 2024

May 03, 2024

SELL
$268.87 - $324.56 $1.1 Million - $1.33 Million
-4,089 Reduced 53.75%
3,518 $1 Million
Q4 2023

Feb 12, 2024

SELL
$255.7 - $288.46 $29,916 - $33,749
-117 Reduced 1.51%
7,607 $2.19 Million
Q3 2023

Nov 02, 2023

SELL
$218.65 - $271.46 $495,460 - $615,128
-2,266 Reduced 22.68%
7,724 $2.08 Million
Q2 2023

Jul 17, 2023

BUY
$214.27 - $253.37 $1.31 Million - $1.55 Million
6,102 Added 156.94%
9,990 $2.22 Million
Q4 2022

Feb 09, 2023

SELL
$229.03 - $291.01 $615,632 - $782,234
-2,688 Reduced 40.88%
3,888 $1.02 Million
Q3 2022

Nov 10, 2022

SELL
$224.46 - $253.15 $41,974 - $47,339
-187 Reduced 2.77%
6,576 $1.48 Million
Q2 2022

Aug 03, 2022

BUY
$230.71 - $256.74 $1.03 Million - $1.14 Million
4,449 Added 192.26%
6,763 $1.65 Million
Q1 2022

May 03, 2022

SELL
$219.27 - $242.57 $1.02 Million - $1.13 Million
-4,645 Reduced 66.75%
2,314 $560,000
Q4 2021

Feb 01, 2022

SELL
$198.88 - $227.6 $3.14 Million - $3.59 Million
-15,769 Reduced 69.38%
6,959 $1.57 Million
Q3 2021

Oct 08, 2021

BUY
$212.27 - $248.7 $363,618 - $426,023
1,713 Added 8.15%
22,728 $4.83 Million
Q2 2021

Aug 05, 2021

BUY
$233.58 - $259.14 $570,402 - $632,819
2,442 Added 13.15%
21,015 $5.12 Million
Q1 2021

Apr 14, 2021

BUY
$221.91 - $258.6 $3.1 Million - $3.61 Million
13,952 Added 301.93%
18,573 $4.62 Million
Q1 2021

Apr 13, 2021

SELL
$221.91 - $258.6 $3.61 Million - $4.21 Million
-16,278 Reduced 77.89%
4,621 $1.15 Million
Q4 2020

Feb 08, 2021

BUY
$216.38 - $257.67 $244,509 - $291,167
1,130 Added 5.72%
20,899 $4.81 Million
Q3 2020

Nov 12, 2020

SELL
$234.65 - $260.95 $135,862 - $151,090
-579 Reduced 2.85%
19,769 $5.02 Million
Q2 2020

Jul 22, 2020

SELL
$197.81 - $242.74 $314,913 - $386,442
-1,592 Reduced 7.26%
20,348 $4.8 Million
Q1 2020

May 22, 2020

SELL
$182.24 - $241.7 $24.3 Million - $32.3 Million
-133,554 Reduced 85.89%
21,940 $4.45 Million
Q1 2020

May 13, 2020

BUY
$182.24 - $241.7 $24.7 Million - $32.8 Million
135,735 Added 686.95%
155,494 $1.29 Million
Q4 2019

Feb 12, 2020

BUY
$189.21 - $243.2 $647,098 - $831,744
3,420 Added 20.93%
19,759 $4.76 Million
Q3 2019

Nov 07, 2019

SELL
$174.11 - $208.62 $2.33 Million - $2.79 Million
-13,384 Reduced 45.03%
16,339 $3.16 Million
Q2 2019

Jul 19, 2019

BUY
$166.7 - $195.41 $21,170 - $24,817
127 Added 0.43%
29,723 $5.48 Million
Q1 2019

May 14, 2019

BUY
$180.87 - $203.88 $614,234 - $692,376
3,396 Added 12.96%
29,596 $5.62 Million
Q4 2018

Apr 29, 2019

SELL
$178.4 - $208.25 $8.87 Million - $10.4 Million
-49,715 Reduced 65.49%
26,200 $5.1 Million
Q4 2018

Feb 07, 2019

BUY
$178.4 - $208.25 $5.32 Million - $6.21 Million
29,804 Added 64.64%
75,915 $14.8 Million
Q3 2018

Nov 13, 2018

SELL
$185.29 - $208.89 $107,653 - $121,365
-581 Reduced 1.24%
46,111 $9.56 Million
Q2 2018

Aug 08, 2018

BUY
$166.05 - $186.51 $627,835 - $705,194
3,781 Added 8.81%
46,692 $8.62 Million
Q1 2018

May 02, 2018

SELL
$169.43 - $198.0 $1.7 Million - $1.99 Million
-10,031 Reduced 18.95%
42,911 $7.32 Million
Q4 2017

Feb 09, 2018

BUY
$168.79 - $188.59 $103,974 - $116,171
616 Added 1.18%
52,942 $9.21 Million
Q3 2017

Nov 03, 2017

BUY
$167.29 - $191.0 $241,399 - $275,613
1,443 Added 2.84%
52,326 $9.76 Million
Q2 2017

Aug 11, 2017

BUY
N/A
50,883
50,883 $8.76 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track F Dx Advisors, Inc. Portfolio

Follow F Dx Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.